vs
Side-by-side financial comparison of Distribution Solutions Group, Inc. (DSGR) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $518.0M, roughly 1.2× Distribution Solutions Group, Inc.). Royalty Pharma plc runs the higher net margin — 34.4% vs 1.2%, a 33.2% gap on every dollar of revenue. On growth, Distribution Solutions Group, Inc. posted the faster year-over-year revenue change (10.7% vs 4.8%). Over the past eight quarters, Distribution Solutions Group, Inc.'s revenue compounded faster (13.1% CAGR vs 4.6%).
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
DSGR vs RPRX — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $518.0M | $622.0M |
| Net Profit | $6.5M | $214.2M |
| Gross Margin | 32.9% | — |
| Operating Margin | 4.6% | 62.4% |
| Net Margin | 1.2% | 34.4% |
| Revenue YoY | 10.7% | 4.8% |
| Net Profit YoY | -70.6% | 2.9% |
| EPS (diluted) | $0.14 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $622.0M | ||
| Q3 25 | $518.0M | $609.3M | ||
| Q2 25 | $502.4M | $578.7M | ||
| Q1 25 | $478.0M | $568.2M | ||
| Q4 24 | $480.5M | $593.6M | ||
| Q3 24 | $468.0M | $564.7M | ||
| Q2 24 | $439.5M | $537.3M | ||
| Q1 24 | $416.1M | $568.0M |
| Q4 25 | — | $214.2M | ||
| Q3 25 | $6.5M | $288.2M | ||
| Q2 25 | $5.0M | $30.2M | ||
| Q1 25 | $3.3M | $238.3M | ||
| Q4 24 | $-25.9M | $208.2M | ||
| Q3 24 | $21.9M | $544.0M | ||
| Q2 24 | $1.9M | $102.0M | ||
| Q1 24 | $-5.2M | $4.8M |
| Q4 25 | — | — | ||
| Q3 25 | 32.9% | — | ||
| Q2 25 | 33.9% | — | ||
| Q1 25 | 34.3% | — | ||
| Q4 24 | 33.3% | — | ||
| Q3 24 | 33.9% | — | ||
| Q2 24 | 34.5% | — | ||
| Q1 24 | 34.5% | — |
| Q4 25 | — | 62.4% | ||
| Q3 25 | 4.6% | 70.1% | ||
| Q2 25 | 5.3% | 36.3% | ||
| Q1 25 | 4.2% | 94.0% | ||
| Q4 24 | 4.2% | 60.9% | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 3.2% | 50.2% | ||
| Q1 24 | 0.7% | -13.0% |
| Q4 25 | — | 34.4% | ||
| Q3 25 | 1.2% | 47.3% | ||
| Q2 25 | 1.0% | 5.2% | ||
| Q1 25 | 0.7% | 41.9% | ||
| Q4 24 | -5.4% | 35.1% | ||
| Q3 24 | 4.7% | 96.3% | ||
| Q2 24 | 0.4% | 19.0% | ||
| Q1 24 | -1.3% | 0.8% |
| Q4 25 | — | $0.49 | ||
| Q3 25 | $0.14 | $0.67 | ||
| Q2 25 | $0.11 | $0.07 | ||
| Q1 25 | $0.07 | $0.55 | ||
| Q4 24 | $-0.55 | $0.46 | ||
| Q3 24 | $0.46 | $1.21 | ||
| Q2 24 | $0.04 | $0.23 | ||
| Q1 24 | $-0.11 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $69.2M | $618.7M |
| Total DebtLower is stronger | $665.5M | $9.0B |
| Stockholders' EquityBook value | $653.9M | $9.7B |
| Total Assets | $1.8B | $19.6B |
| Debt / EquityLower = less leverage | 1.02× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $618.7M | ||
| Q3 25 | $69.2M | $938.9M | ||
| Q2 25 | $47.4M | $631.9M | ||
| Q1 25 | $65.4M | $1.1B | ||
| Q4 24 | $66.5M | $929.0M | ||
| Q3 24 | $61.3M | $950.1M | ||
| Q2 24 | $46.8M | $1.8B | ||
| Q1 24 | $73.1M | $843.0M |
| Q4 25 | — | $9.0B | ||
| Q3 25 | $665.5M | $8.9B | ||
| Q2 25 | $675.0M | $8.0B | ||
| Q1 25 | $712.4M | $7.6B | ||
| Q4 24 | $693.9M | $7.6B | ||
| Q3 24 | $704.1M | $7.6B | ||
| Q2 24 | $573.7M | $7.6B | ||
| Q1 24 | $535.7M | $6.1B |
| Q4 25 | — | $9.7B | ||
| Q3 25 | $653.9M | $9.6B | ||
| Q2 25 | $649.4M | $9.5B | ||
| Q1 25 | $636.7M | $9.8B | ||
| Q4 24 | $640.5M | $10.3B | ||
| Q3 24 | $680.8M | $10.3B | ||
| Q2 24 | $653.3M | $9.8B | ||
| Q1 24 | $654.7M | $9.9B |
| Q4 25 | — | $19.6B | ||
| Q3 25 | $1.8B | $19.3B | ||
| Q2 25 | $1.8B | $18.3B | ||
| Q1 25 | $1.8B | $17.6B | ||
| Q4 24 | $1.7B | $18.2B | ||
| Q3 24 | $1.8B | $18.0B | ||
| Q2 24 | $1.6B | $17.7B | ||
| Q1 24 | $1.5B | $16.1B |
| Q4 25 | — | 0.92× | ||
| Q3 25 | 1.02× | 0.93× | ||
| Q2 25 | 1.04× | 0.84× | ||
| Q1 25 | 1.12× | 0.78× | ||
| Q4 24 | 1.08× | 0.74× | ||
| Q3 24 | 1.03× | 0.74× | ||
| Q2 24 | 0.88× | 0.78× | ||
| Q1 24 | 0.82× | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $38.4M | $827.1M |
| Free Cash FlowOCF − Capex | $32.9M | — |
| FCF MarginFCF / Revenue | 6.3% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | 5.95× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $92.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $827.1M | ||
| Q3 25 | $38.4M | $702.6M | ||
| Q2 25 | $33.3M | $364.0M | ||
| Q1 25 | $-4.8M | $596.1M | ||
| Q4 24 | $45.7M | $742.5M | ||
| Q3 24 | $-17.3M | $703.6M | ||
| Q2 24 | $21.4M | $658.2M | ||
| Q1 24 | $6.6M | $664.6M |
| Q4 25 | — | — | ||
| Q3 25 | $32.9M | — | ||
| Q2 25 | $28.7M | — | ||
| Q1 25 | $-10.4M | — | ||
| Q4 24 | $41.1M | — | ||
| Q3 24 | $-20.5M | — | ||
| Q2 24 | $18.0M | — | ||
| Q1 24 | $4.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | 6.3% | — | ||
| Q2 25 | 5.7% | — | ||
| Q1 25 | -2.2% | — | ||
| Q4 24 | 8.6% | — | ||
| Q3 24 | -4.4% | — | ||
| Q2 24 | 4.1% | — | ||
| Q1 24 | 1.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | — | 3.86× | ||
| Q3 25 | 5.95× | 2.44× | ||
| Q2 25 | 6.66× | 12.06× | ||
| Q1 25 | -1.46× | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | -0.79× | 1.29× | ||
| Q2 24 | 11.28× | 6.45× | ||
| Q1 24 | — | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DSGR
| Test Equity Segment | $206.5M | 40% |
| Gexpro Services Segment | $130.5M | 25% |
| Lawson Segment | $121.5M | 23% |
| Canada Branch Division Segment | $60.0M | 12% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
